UGDH and breast cancer: Several additional studies in BC have further established that higher levels of UGDH are associated with worse prognoses for patients (particularly those with triple negative breast cancer (TNBC) receiving chemotherapy [5]) and more invasive, metastatic phenotypes in BC samples [9, 10].